Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease
Journal of Experimental Medicine · 02.12.2024 · 221 (12)
DOI: 10.1084/jem.20240942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 01.11.2024. Verfasst von Adrian Gervais und 37 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker …. Hauptthemen laut MEDLINE: Interferon Type I, Ross River virus, Encephalitis, Tick-Borne, Antibodies, Neutralizing. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Foundation for Medical Research, Meyer Foundation, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Arboviral diseases are a growing global health concern. Pre-existing autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) can underlie encephalitis due to West Nile virus (WNV) (∼40% of patients) and tick-borne encephalitis (TBE, due to TBE virus [TBEV]) (∼10%). We report here that these auto-Abs can also underlie severe forms of rarer arboviral infections. Auto-Abs neutralizing high concentrations of IFN-α2, IFN-β, and/or IFN-ω are present in the single case of severe Powassan virus (POWV) encephalitis studied, two of three cases of severe Usutu virus (USUV) infection studied, and the most severe of 24 cases of Ross River virus (RRV) disease studied. These auto-Abs are not found in any of the 137 individuals with silent or mild infections with these three viruses. Thus, auto-Abs neutralizing type I IFNs underlie an increasing list of severe arboviral diseases due to Flaviviridae (WNV, TBEV, POWV, USUV) or Togaviridae (RRV) viruses transmitted to humans by mosquitos (WNV, USUV, RRV) or ticks (TBEV, POWV).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
- Imagine Institute, Paris Cité University , Paris, France.
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
- Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
- Établissement Français du Sang , La Plaine Saint-Denis, France.
- Faculty of Medicine, School of Biomedical Sciences, UNSW Australia, Sydney, Australia.
ORCID-Profile: Adrian Gervais, Paul Bastard, Lucy Bizien, Céline Delifer, Pierre Tiberghien, Chaturaka Rodrigo, Francesca Trespidi, Micol Angelini, Giada Rossini, Tiziana Lazzarotto, Francesca Conti, Irene Cassaniti, Fausto Baldanti, Francesca Rovida, Alessandro Ferrari, Davide Mileto, Alessandro Mancon, Laurent Abel, Anne Puel, Aurélie Cobat, Charles M Rice, Dániel Cadar, Jonas Schmidt-Chanasit, Johannes F Scheid, Jacob E Lemieux, Eric S Rosenberg, Marianna Agudelo, Stuart G Tangye, Alessandro Borghesi, Guillaume André Durand, Emilie Duburcq-Gury, Braulio M Valencia, Andrew R Lloyd, Anna Nagy, Margaret M MacDonald, Yannick Simonin, Shen-Ying Zhang, Jean-Laurent Casanova
Förderung
- French Foundation for Medical Research
- Meyer Foundation
- Agence Nationale de la Recherche
- National Health and Medical Research Council of Australia
- San Matteo Hospital
- Imagine Institute
- NIAID NIH HHS
- Paris Cité University
Zitieren
APA
Gervais, A., Bastard, P., Bizien, L., Delifer, C., Tiberghien, P., Rodrigo, C., Trespidi, F., Angelini, M., Rossini, G., Lazzarotto, T., Conti, F., Cassaniti, I., Baldanti, F., Rovida, F., Ferrari, A., Mileto, D., Mancon, A., Abel, L., Puel, A., …, & Casanova, J. L. (2024). Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease. Journal of Experimental Medicine, 221(12). https://doi.org/10.1084/jem.20240942
Vancouver
Gervais A, Bastard P, Bizien L, Delifer C, Tiberghien P, Rodrigo C, et al. Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease. Journal of Experimental Medicine. 2024;221(12). doi:10.1084/jem.20240942
BibTeX
@article{Gervais2024,
author = {Gervais, Adrian and Bastard, Paul and Bizien, Lucy and Delifer, Céline and Tiberghien, Pierre and Rodrigo, Chaturaka and Trespidi, Francesca and Angelini, Micol and Rossini, Giada and Lazzarotto, Tiziana and Conti, Francesca and Cassaniti, Irene and Baldanti, Fausto and Rovida, Francesca and Ferrari, Alessandro and Mileto, Davide and Mancon, Alessandro and Abel, Laurent and Puel, Anne and Cobat, Aurélie and Rice, Charles M and Cadar, Dániel and Schmidt-Chanasit, Jonas and Scheid, Johannes F and Lemieux, Jacob E and Rosenberg, Eric S and Agudelo, Marianna and Tangye, Stuart G and Borghesi, Alessandro and Durand, Guillaume André and Duburcq-Gury, Emilie and Valencia, Braulio M and Lloyd, Andrew R and Nagy, Anna and MacDonald, Margaret M and Simonin, Yannick and Zhang, Shen-Ying and Casanova, Jean-Laurent},
title = {Auto-Abs neutralizing type I IFNs in patients with severe Powassan, Usutu, or Ross River virus disease},
journal = {Journal of Experimental Medicine},
year = {2024},
volume = {221},
number = {12},
doi = {10.1084/jem.20240942}
}
EUVIMED